Baxter International Inc. Stock London S.E.
Equities
0QK8
US0718131099
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
36.35 USD | +7.32% | +7.58% | -6.44% |
Financials (USD)
Sales 2024 * | 15.11B | Sales 2025 * | 15.66B | Capitalization | 16.9B |
---|---|---|---|---|---|
Net income 2024 * | 703M | Net income 2025 * | 950M | EV / Sales 2024 * | 1.77 x |
Net Debt 2024 * | 9.85B | Net Debt 2025 * | 9.06B | EV / Sales 2025 * | 1.66 x |
P/E ratio 2024 * |
18
x | P/E ratio 2025 * |
14.8
x | Employees | 60,000 |
Yield 2024 * |
3.6% | Yield 2025 * |
3.74% | Free-Float | 74.27% |
Latest transcript on Baxter International Inc.
1 day | +7.32% | ||
1 week | +7.58% | ||
Current month | +7.58% | ||
1 month | +0.86% | ||
3 months | -17.08% | ||
6 months | +0.58% | ||
Current year | -6.44% |
Managers | Title | Age | Since |
---|---|---|---|
Joe Almeida
CEO | Chief Executive Officer | 61 | 15-09-30 |
Joel Grade
DFI | Director of Finance/CFO | 54 | 23-10-17 |
Reaz Rasul
CTO | Chief Tech/Sci/R&D Officer | - | 16-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Oesterle
BRD | Director/Board Member | 73 | 17-02-05 |
Peter Wilver
BRD | Director/Board Member | 64 | 22-05-09 |
Director/Board Member | 64 | 19-02-17 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 33.08 | -1.27% | 3,585 |
24-06-06 | 33.5 | +1.45% | 1,294 |
24-06-05 | 33.02 | -1.40% | 1,747 |
24-06-04 | 33.49 | -2.22% | 571 |
24-06-03 | 34.25 | +1.36% | 903 |
Delayed Quote London S.E., December 12, 2023 at 10:52 am EST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.26% | 187B | |
+2.05% | 110B | |
-1.31% | 69.54B | |
+14.65% | 46.37B | |
-6.69% | 46.05B | |
+7.97% | 42.54B | |
+18.60% | 30.72B | |
+16.92% | 25.62B | |
-6.87% | 23.32B |
- Stock Market
- Equities
- BAX Stock
- 0QK8 Stock